AstraZeneca Press Release (01/11/12)
AstraZeneca has announced that it has entered into a three-year collaboration agreement with IMS Health, a provider of information, services and technology for the healthcare sector, to advance the use of real-world evidence based on observational and retrospective studies throughout Europe to inform the delivery of effective and cost-efficient healthcare. The partnership will give AstraZeneca access to pre-existing electronic health records, which include clinical outcome, economic and treatment pattern data. In addition, the companies will jointly develop a customized research and data analysis platform. The information will provide a deeper insight into how medicines that are already on the market are working in real-world settings across Europe, painting a picture of unmet needs in the current standard of care and treatment patterns across a number of therapeutic areas, with an emphasis on chronic illnesses. The data will also be used to inform AstraZeneca's discovery and clinical development programs.

Read the complete article